|
|
Wiskott-Aldrich syndrome protein (WASp) signaling in the oncogenesis of T cell lymphomas
|
5K08CA218460-02
|
$106,531
|
$53,266
|
MURGA-ZAMALLOA, CARLOS
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S1
|
$72,918
|
$13,854
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S2
|
$200,473
|
$38,090
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-10S3
|
$234,000
|
$44,460
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
5P30CA138292-10
|
$2,574,000
|
$489,060
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer
|
5K07CA204201-03
|
$176,941
|
$176,941
|
ENZINGER, ANDREA
|
DANA-FARBER CANCER INST
|
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
3R01CA184456-03S2
|
$65,611
|
$21,652
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
5R01CA184456-03
|
$341,981
|
$112,854
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S1
|
$218,356
|
$41,488
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S2
|
$203,848
|
$38,731
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-37S3
|
$86,197
|
$16,377
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Massey Cancer Center Support Grant
|
5P30CA016059-37
|
$2,170,000
|
$412,300
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Validation of a genomic signature that predicts for sub-optimal debulking of epithelial ovarian cancer
|
1R21CA218973-01A1
|
$203,042
|
$203,042
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$532,008
|
$532,008
|
Hodge, James
|
CCR (NCI)
|
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$532,008
|
$266,004
|
Hodge, James
|
CCR (NCI)
|
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
2P30CA014520-44
|
$4,590,130
|
$321,309
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S1
|
$250,000
|
$17,500
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S2
|
$136,232
|
$9,536
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S3
|
$75,711
|
$5,300
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive CANCER CENTER SUPPORT
|
3P30CA014520-44S4
|
$31,772
|
$2,224
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Utilizing MEK Inhibition to Sensitize Microsatellite Stable Colorectal Cancer to Immune Checkpoint Therapy
|
1R01CA229259-01
|
$247,340
|
$247,340
|
LIEU, CHRISTOPHER
|
UNIVERSITY OF COLORADO DENVER
|
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-05
|
$379,294
|
$379,294
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Using Second Harmonic Generation to Predict Metastatic Outcome in Colon Adenocarcinoma
|
5R21CA208921-02
|
$167,475
|
$167,475
|
BROWN, EDWARD
|
UNIVERSITY OF ROCHESTER
|
|
|
Using patient-derived models to understand drug responses in SCLC
|
1U01CA220323-01A1
|
$619,923
|
$619,923
|
DYSON, NICHOLAS
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Using 18F-EF5 PET to measure hypoxia modulation by Nelfinavir in larynx cancer
|
5R01CA174976-05
|
$351,104
|
$351,104
|
MAITY, AMIT
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-43S1
|
$40,593
|
$2,436
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
5P30CA014089-43
|
$6,268,475
|
$376,109
|
FARNHAM, PEGGY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
|
3U54CA096300-15S2
|
$400,000
|
$64,000
|
TRAVIS, ELIZABETH
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S1
|
$247,355
|
$9,894
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S2
|
$35,000
|
$1,400
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S3
|
$124,862
|
$4,994
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S4
|
$48,726
|
$1,949
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S5
|
$174,039
|
$6,962
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
|
University of Virginia Cancer Center Support Grant
|
3P30CA044579-27S6
|
$107,460
|
$4,298
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
|
University of Virginia Cancer Center Support Grant
|
5P30CA044579-27
|
$2,599,349
|
$103,974
|
LOUGHRAN, THOMAS
|
UNIVERSITY OF VIRGINIA
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S1
|
$113,625
|
$6,818
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S2
|
$60,000
|
$3,600
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S3
|
$250,001
|
$15,000
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S4
|
$200,000
|
$12,000
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S5
|
$125,000
|
$7,500
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S6
|
$300,000
|
$18,000
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S7
|
$241,885
|
$14,513
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
3P30CA118100-14S8
|
$293,284
|
$17,597
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
University of New Mexico Cancer Center Support Grant
|
5P30CA118100-14
|
$2,246,011
|
$134,761
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S1
|
$629,550
|
$113,319
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S2
|
$200,000
|
$36,000
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
3P30CA134274-11S3
|
$125,000
|
$22,500
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
|
5P30CA134274-11
|
$2,266,216
|
$407,919
|
CULLEN, KEVIN
|
UNIVERSITY OF MARYLAND BALTIMORE
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
2P30CA177558-06
|
$2,152,710
|
$473,596
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
|
University of Kentucky Markey Cancer Center - Cancer Center Support Grant
|
3P30CA177558-06S1
|
$101,000
|
$22,220
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
Total relevant funding to Chemotherapy for this search: $339,941,866
|
